Identification of early response genes to roughness and fluoride modification of titanium implants in human osteoblasts

Implant Dentistry

Volumn 21, Issue 2, 2012, Pages 141-149

  Ramis, Joana Maria ^a   Taxt Lamolle, Sébastien Francis ^b   Lyngstadaas, Staale Petter ^b   Reseland, Janne Elin ^b   Ellingsen, Jan Eirik ^b   Monjo, Marta ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

fluoride; gene expression; microarray; osteoblast; roughness; titanium

Indexed keywords

ANKH PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BIOMATERIAL; COLLAGEN TYPE 1; DCN PROTEIN, HUMAN; DECORIN; DENTAL MATERIAL; DISTAL LESS HOMEOBOX PROTEINS; DISTAL-LESS HOMEOBOX PROTEINS; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; ENAMEL PROTEIN; FLUORIDE; FOLLISTATIN; FST PROTEIN, HUMAN; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; INORGANIC PYROPHOSPHATASE; OSTEOCALCIN; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE TRANSPORTER; PHOSPHODIESTERASE; RUNX2 PROTEIN, HUMAN; THYROID HORMONE RECEPTOR ALPHA; TITANIUM; TITANIUM DIOXIDE; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TUFTELIN;

ARTICLE; BONE MINERALIZATION; CHEMISTRY; CULTURE TECHNIQUE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MICROARRAY ANALYSIS; OSTEOBLAST; PHYSIOLOGY; SURFACE PROPERTY; TOOTH IMPLANT; TOOTH PROSTHESIS;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIFICATION, PHYSIOLOGIC; CELL CULTURE TECHNIQUES; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN TYPE I; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DECORIN; DENTAL ENAMEL PROTEINS; DENTAL IMPLANTS; DENTAL MATERIALS; DENTAL PROSTHESIS DESIGN; FLUORIDES; FOLLISTATIN; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; MICROARRAY ANALYSIS; OSTEOBLASTS; OSTEOCALCIN; PARATHYROID HORMONE-RELATED PROTEIN; PHOSPHATE TRANSPORT PROTEINS; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; SURFACE PROPERTIES; THYROID HORMONE RECEPTORS ALPHA; TITANIUM; TOLL-LIKE RECEPTOR 3; TRANSCRIPTION FACTORS;

EID: 84859155587     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/ID.0b013e31824a06b4     Document Type: Article

References (48)

1. Ellingsen JE. Pre-treatment of titanium implants with fluoride improves their retention in bone. J Mater Sci-Mater Med. 1995;6:749-753. (Pubitemid 26014586)
2. Ellingsen JE, Thomsen P, Lyngstadaas SP. Advances in dental implant materials and tissue regeneration. Periodontol 2000. 2006;41:136-156. (Pubitemid 43941205)
3. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2001;10(suppl 2):S96-S101. (Pubitemid 32999812)
4. Cooper LF, Zhou Y, Takebe J, et al. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 gritblasted c.p. titanium endosseous implants. Biomaterials. 2006;27:926-936. (Pubitemid 41484125)
5. Guo J, Padilla RJ, Ambrose W, et al. The effect of hydrofluoric acid treatment of TiO(2) grit blasted titanium implants on adherent osteoblast gene expression in vitro and in vivo. Biomaterials. 2007;28: 5418-5425. (Pubitemid 47599637)
6. Isa ZM, Schneider GB, Zaharias R, et al. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. Int J Oral Maxillofac Implants. 2006;21:203-211. (Pubitemid 43652364)
7. Masaki C, Schneider GB, Zaharias R, et al. Effects of implant surface microtopography on osteoblast gene expression. Clin Oral Implants Res. 2005; 16:650-656. (Pubitemid 43951427)
8. Lamolle SF, Monjo M, Rubert M, et al. The effect of hydrofluoric acid treatment of titanium surface on nanostructural and chemical changes and the growth of MC3T3-E1 cells. Biomaterials. 2009;30: 736-742.
9. Jimbo R, Sawase T, Baba K, et al. Enhanced initial cell responses to chemically modified anodized titanium. Clin Implant Dent Relat Res. 2008;10:55-61.
10. Thor A, Rasmusson L, Wennerberg A, et al. The role of whole blood in thrombin generation in contact with various titanium surfaces. Biomaterials. 2007; 28:966-974. (Pubitemid 44809427)
11. Ellingsen JE, Johansson CB, Wennerberg A, et al. Improved retention and bone-to-implant contact with fluoridemodified titanium implants. Int J Oral Maxillofac Implants. 2004;19:659-666. (Pubitemid 39430453)
12. Berglundh T, Abrahamsson I, Albouy JP, et al. Bone healing at implants with a fluoride-modified surface: An experimental study in dogs. Clin Oral Implants Res. 2007;18:147-152.
13. Monjo M, Lamolle SF, Lyngstadaas SP, et al. In vivo expression of osteogenic markers and bone mineral density at the surface of fluoride-modified titanium implants. Biomaterials. 2008;29:3771-3780.
14. Li Y, Zou S, Wang D, et al. The effect of hydrofluoric acid treatment on titanium implant osseointegration in ovariectomized rats. Biomaterials. 2010;31: 3266-3273.
15. Kim Y, Jang JH, Ku Y, et al. Microarray-based expression analysis of human osteoblast-like cell response to anodized titanium surface. Biotechnol Lett. 2004;26:399-402. (Pubitemid 38377635)
16. Gotfredsen K, Berglundh T, Lindhe J. Anchorage of titanium implants with different surface characteristics: An experimental study in rabbits. Clin Implant Dent Relat Res. 2000;2:120-128.
17. Wong M, Eulenberger J, Schenk R, et al. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res. 1995; 29:1567-1575.
18. Ronold HJ, Ellingsen JE. Effect of micro-roughness produced by TiO2 blasting-tensile testing of bone attachment by using coin-shaped implants. Biomaterials. 2002;23:4211-4219. (Pubitemid 34814990)
19. Ellingsen JE. Surface configurations of dental implants. Periodontol 2000. 1998;17:36-46. (Pubitemid 128556015)
20. Lamolle SF, Monjo M, Lyngstadaas SP, et al. Titanium implant surface modification by cathodic reduction in hydrofluoric acid: Surface characterization and in vivo performance. J Biomed Mater Res A. 2009;88:581-588.
21. Liu G, Loraine AE, Shigeta R, et al. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res. 2003;31:82-86.
22. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207-210. (Pubitemid 34679544)
23. Kokubu E, Hamilton DW, Inoue T, et al. Modulation of human gingival fibroblast adhesion, morphology, tyrosine phosphorylation, and ERK 1/2 localization on polished, grooved and SLA substratum topographies. J Biomed Mater Res A. 2009;91:663-670.
24. Biggs MJ, Richards RG, Gadegaard N, et al. Interactions with nanoscale topography: Adhesion quantification and signal transduction in cells of osteogenic and multipotent lineage. J Biomed Mater Res A. 2009;91:195-208.
25. Biggs MJ, Richards RG, Gadegaard N, et al. The use of nanoscale topography to modulate the dynamics of adhesion formation in primary osteoblasts and ERK/MAPK signalling in STRO-1- enriched skeletal stem cells. Biomaterials. 2009;30:5094-5103.
26. Lau KH, Baylink DJ. Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res. 1998;13:1660-1667. (Pubitemid 28491994)
27. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000;289:265-270. (Pubitemid 30469899)
28. Kirsch T, Kim HJ, Winkles JA. Progressive ankylosis gene (ank) regulates osteoblast differentiation. Cells Tissues Organs. 2009;189:158-162.
29. Waddington RJ, Roberts HC, Sugars RV, et al. Differential roles for small leucine-rich proteoglycans in bone formation. Eur Cell Mater. 2003;6:12-21, discussion 21. (Pubitemid 38851418)
30. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3-9. (Pubitemid 38147427)
31. Takami M, Kim N, Rho J, et al. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol. 2002;169:1516-1523. (Pubitemid 34809198)
32. Ryoo HM, Hoffmann HM, Beumer T, et al. Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol. 1997;11: 1681-1694. (Pubitemid 27435416)
33. Simeone A, Acampora D, Pannese M, et al. Cloning and characterization of two members of the vertebrate Dlx gene family. Proc Natl Acad Sci USA. 1994;91: 2250-2254. (Pubitemid 24092081)
34. Harris SE, Guo D, Harris MA, et al. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: Role of Dlx2 and Dlx5 transcription factors. Front Biosci. 2003;8:s1249-1265. (Pubitemid 38925386)
35. Deutsch D. Structure and function of enamel gene products. Anat Rec. 1989; 224:189-210. (Pubitemid 19184418)
36. Deutsch D, Dafni L, Palmon A, et al. Tuftelin: Enamel mineralization and amelogenesis imperfecta. Ciba Found Symp. 1997;205:135-147; discussion 147-155.
37. Deutsch D, Palmon A, Dafni L, et al. The enamelin (tuftelin) gene. Int J Dev Biol. 1995;39:135-143.
38. Deutsch D, Palmon A, Fisher LW, et al. Sequencing of bovine enamelin ("tuftelin") a novel acidic enamel protein. J Biol Chem. 1991;266:16021-16028. (Pubitemid 21907759)
39. Matsue M, Kageyama R, Denhardt DT, et al. Helix-loop-helix-type transcription factor (HES-1) is expressed in osteoblastic cells, suppressed by 1,25(OH)2 vitamin D3, and modulates 1,25(OH)2 vitamin D3 enhancement of osteopontin gene expression. Bone. 1997;20:329-334. (Pubitemid 27196655)
40. Bisello A, Horwitz MJ, Stewart AF. Parathyroid hormone-related protein: An essential physiological regulator of adult bone mass. Endocrinology. 2004;145: 3551-3553. (Pubitemid 39037533)
41. Miao D, He B, Jiang Y, et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest. 2005;115: 2402-2411. (Pubitemid 41266202)
42. Okawa A, Nakamura I, Goto S, et al. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet. 1998;19: 271-273. (Pubitemid 28309341)
43. Stefan C, Jansen S, Bollen M. NPP-type ectophosphodiesterases: Unity in diversity. Trends Biochem Sci. 2005;30: 542-550. (Pubitemid 41356492)
44. Eijken M, Swagemakers S, Koedam M, et al. The activin A-follistatin system: Potent regulator of human extracellular matrix mineralization. FASEB J. 2007;21:2949-2960. (Pubitemid 47372761)
45. Fainsod A, Deissler K, Yelin R, et al. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech Dev. 1997;63:39-50. (Pubitemid 27214501)
46. Iemura S, Yamamoto TS, Takagi C, et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA. 1998;95:9337-9342. (Pubitemid 28506232)
47. Bassett JH, Williams GR. The molecular actions of thyroid hormone in bone. Trends Endocrinol Metab. 2003;14:356-364. (Pubitemid 37236956)
48. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767-773.